Skip to main content

Table 3 The estimated infarction size in patients with AMI

From: Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome

The peak value of myocardial enzyme

Before PS match

P value

After PS match

P value

ACEI/ARB(-)

ACEI/ARB(+)

ACEI/ARB(-)

ACEI/ARB(+)

(n: 402)

(n: 251)

(n: 298)

(n: 236)

pMYO,ng/ml

50.1 (26.0, 150.3)

46.0 (17.4, 146.5)

NS

50.4 (28.3, 173.8)

46.1 (17.8, 150.0)

NS

pCK-MB,ng/ml

28.4 (8.0, 116.0)

21.3 (5.2, 89.2)

< 0.05

28.7 (8.2, 119.3)

21.7 (5.2, 90.9)

< 0.05

pTNI,ng/ml

7.7 (2.3, 27.0)

5.4 (1.0, 22.5)

< 0.05

6.8 (2.2, 22.9)

5.7 (1.0, 24.3)

< 0.05

  1. Data are presented as IQR
  2. AMI acute myocardial infarction, ACEI/ARB angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, pMYO the peak value of myoglobin, pCK-MB the peak value of creatine kinase MB, pTNI the peak value of troponin I, NS non-significant